Mark Sheptoff Financial Planning buys $2,354,600 stake in Rite Aid Corporation (RAD)

Rite Aid Corporation (RAD) : Mark Sheptoff Financial Planning scooped up 15,500 additional shares in Rite Aid Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 9, 2016. The investment management firm now holds a total of 311,455 shares of Rite Aid Corporation which is valued at $2,354,600.Rite Aid Corporation makes up approximately 1.75% of Mark Sheptoff Financial Planning’s portfolio.

Other Hedge Funds, Including , Pittenger Anderson Inc boosted its stake in RAD in the latest quarter, The investment management firm added 4,100 additional shares and now holds a total of 19,350 shares of Rite Aid Corporation which is valued at $135,837. Rite Aid Corporation makes up approx 0.01% of Pittenger Anderson Inc’s portfolio.Gabelli Securities boosted its stake in RAD in the latest quarter, The investment management firm added 652,391 additional shares and now holds a total of 2,130,600 shares of Rite Aid Corporation which is valued at $14,871,588. Rite Aid Corporation makes up approx 2.24% of Gabelli Securities’s portfolio. Quantitative Investment Management sold out all of its stake in RAD during the most recent quarter. The investment firm sold 253,600 shares of RAD which is valued $1,770,128.Sphinx Trading Lp boosted its stake in RAD in the latest quarter, The investment management firm added 20,000 additional shares and now holds a total of 28,000 shares of Rite Aid Corporation which is valued at $190,960. Rite Aid Corporation makes up approx 1.53% of Sphinx Trading Lp’s portfolio.

Rite Aid Corporation closed down -0.07 points or -0.91% at $7.63 with 80,57,338 shares getting traded on Wednesday. Post opening the session at $7.67, the shares hit an intraday low of $7.615 and an intraday high of $7.71 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Rite Aid Corporation reported $0.01 EPS for the quarter, missing the analyst consensus estimate by $ -0.03 based on the information available during the earnings call on Jun 16, 2016. Analyst had a consensus of $0.04. The company had revenue of $8184.20 million for the quarter, compared to analysts expectations of $8200.56 million. The company’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.04 EPS.

Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise which are referred to as front-end products. The Company’s drugstores’ primary business is pharmacy services. It operates approximately 4570 stores in 31 states across the country and in the District of Columbia. Its front-end products include over-the-counter medications health and beauty aids personal care items cosmetics household items food and beverages greeting cards seasonal merchandise and various other every day and convenience products. The Company offers a range of products through its portfolio of private brands. Its classes of products include prescription drugs over-the-counter medications and personal care health and beauty aids and general merchandise and other. It sells private brand and co-branded products. It operates under The Rite Aid name.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *